BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 35414060)

  • 21. Metabolic reprogramming in triple-negative breast cancer through Myc suppression of TXNIP.
    Shen L; O'Shea JM; Kaadige MR; Cunha S; Wilde BR; Cohen AL; Welm AL; Ayer DE
    Proc Natl Acad Sci U S A; 2015 Apr; 112(17):5425-30. PubMed ID: 25870263
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ROS-mediated activation and mitochondrial translocation of CaMKII contributes to Drp1-dependent mitochondrial fission and apoptosis in triple-negative breast cancer cells by isorhamnetin and chloroquine.
    Hu J; Zhang Y; Jiang X; Zhang H; Gao Z; Li Y; Fu R; Li L; Li J; Cui H; Gao N
    J Exp Clin Cancer Res; 2019 May; 38(1):225. PubMed ID: 31138329
    [TBL] [Abstract][Full Text] [Related]  

  • 23. YTHDF1 enhances stemness and chemoresistance in triple-negative breast cancer cells by upregulating SIAH2.
    Wu A; Wang X; Zhang F; Yang X; Quan Y; Dong J; Lai Y; Yang D; Sun J; Wang M
    Mol Carcinog; 2024 Mar; 63(3):417-429. PubMed ID: 37983722
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Piperlongumine Induces Apoptosis and Synergizes with Doxorubicin by Inhibiting the JAK2-STAT3 Pathway in Triple-Negative Breast Cancer.
    Chen D; Ma Y; Li P; Liu M; Fang Y; Zhang J; Zhang B; Hui Y; Yin Y
    Molecules; 2019 Jun; 24(12):. PubMed ID: 31242627
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HORMAD1 promotes docetaxel resistance in triple negative breast cancer by enhancing DNA damage tolerance.
    Zong B; Sun L; Peng Y; Wang Y; Yu Y; Lei J; Zhang Y; Guo S; Li K; Liu S
    Oncol Rep; 2021 Jul; 46(1):. PubMed ID: 34036395
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rad51 Silencing with siRNA Delivered by Porous Silicon-Based Microparticle Enhances the Anti-Cancer Effect of Doxorubicin in Triple-Negative Breast Cancer.
    Wu Z; Zhu L; Mai J; Shen H; Xu R
    J Biomed Nanotechnol; 2021 Dec; 17(12):2351-2363. PubMed ID: 34974858
    [TBL] [Abstract][Full Text] [Related]  

  • 27. APC loss affects DNA damage repair causing doxorubicin resistance in breast cancer cells.
    Stefanski CD; Keffler K; McClintock S; Milac L; Prosperi JR
    Neoplasia; 2019 Dec; 21(12):1143-1150. PubMed ID: 31759252
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CENPF knockdown inhibits adriamycin chemoresistance in triple-negative breast cancer via the Rb-E2F1 axis.
    Wang D; Xu W; Huang M; Ma W; Liu Y; Zhou X; Yang Q; Mu K
    Sci Rep; 2023 Jan; 13(1):1803. PubMed ID: 36720923
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SRSF1 inhibits ferroptosis and reduces cisplatin chemosensitivity of triple-negative breast cancer cells through the circSEPT9/GCH1 axis.
    Song X; Wang X; Chen X; Yu Z; Zhou Y
    J Proteomics; 2024 Feb; 292():105055. PubMed ID: 38040194
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mint3-depletion-induced energy stress sensitizes triple-negative breast cancer to chemotherapy via HSF1 inactivation.
    Tanaka N; Okada H; Yamaguchi K; Seki M; Matsubara D; Gotoh N; Suzuki Y; Furukawa Y; Yamashita T; Inoue JI; Kaneko S; Sakamoto T
    Cell Death Dis; 2023 Dec; 14(12):815. PubMed ID: 38081808
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Danggui Buxue Tang improves therapeutic efficacy of doxorubicin in triple negative breast cancer via ferroptosis.
    Gong G; Ganesan K; Liu Y; Huang Y; Luo Y; Wang X; Zhang Z; Zheng Y
    J Ethnopharmacol; 2024 Apr; 323():117655. PubMed ID: 38158099
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interference KRT17 reverses doxorubicin resistance in triple-negative breast cancer cells by Wnt/β-catenin signaling pathway.
    Wu L; Ding W; Wang X; Li X; Yang J
    Genes Genomics; 2023 Oct; 45(10):1329-1338. PubMed ID: 37634232
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CARP-1 functional mimetics are novel inhibitors of drug-resistant triple negative breast cancers.
    Cheriyan VT; Muthu M; Patel K; Sekhar S; Rajeswaran W; Larsen SD; Polin L; Levi E; Singh M; Rishi AK
    Oncotarget; 2016 Nov; 7(45):73370-73388. PubMed ID: 27687593
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Curcumol enhances the sensitivity of doxorubicin in triple-negative breast cancer via regulating the miR-181b-2-3p-ABCC3 axis.
    Zeng C; Fan D; Xu Y; Li X; Yuan J; Yang Q; Zhou X; Lu J; Zhang C; Han J; Gu J; Gao Y; Sun L; Wang S
    Biochem Pharmacol; 2020 Apr; 174():113795. PubMed ID: 31926937
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diterpenoid natural compound C4 (Crassin) exerts cytostatic effects on triple-negative breast cancer cells via a pathway involving reactive oxygen species.
    Richards CE; Vellanki SH; Smith YE; Hopkins AM
    Cell Oncol (Dordr); 2018 Feb; 41(1):35-46. PubMed ID: 29134467
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Paraoxonase-2 is upregulated in triple negative breast cancer and contributes to tumor progression and chemoresistance.
    Campagna R; Pozzi V; Giorgini S; Morichetti D; Goteri G; Sartini D; Serritelli EN; Emanuelli M
    Hum Cell; 2023 May; 36(3):1108-1119. PubMed ID: 36897549
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Integrated multiomic data analysis reveals the clinical significance of TXNIP and contributing to immune microenvironment in triple negative breast cancer.
    Gong H; Zhang P; Hu X; Zhang B
    Transl Oncol; 2024 Jan; 39():101808. PubMed ID: 37897832
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ferroptosis-enhanced chemotherapy for triple-negative breast cancer with magnetic composite nanoparticles.
    Zhang J; Zhou K; Lin J; Yao X; Ju D; Zeng X; Pang Z; Yang W
    Biomaterials; 2023 Dec; 303():122395. PubMed ID: 37988899
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MYC and MCL1 Cooperatively Promote Chemotherapy-Resistant Breast Cancer Stem Cells via Regulation of Mitochondrial Oxidative Phosphorylation.
    Lee KM; Giltnane JM; Balko JM; Schwarz LJ; Guerrero-Zotano AL; Hutchinson KE; Nixon MJ; Estrada MV; Sánchez V; Sanders ME; Lee T; Gómez H; Lluch A; Pérez-Fidalgo JA; Wolf MM; Andrejeva G; Rathmell JC; Fesik SW; Arteaga CL
    Cell Metab; 2017 Oct; 26(4):633-647.e7. PubMed ID: 28978427
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Myricetin-induced apoptosis of triple-negative breast cancer cells is mediated by the iron-dependent generation of reactive oxygen species from hydrogen peroxide.
    Knickle A; Fernando W; Greenshields AL; Rupasinghe HPV; Hoskin DW
    Food Chem Toxicol; 2018 Aug; 118():154-167. PubMed ID: 29742465
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.